|
|
Volumn 81, Issue 6, 2004, Pages 1699-1700
|
|
Influence of the Women's Health Initiative trial on the practice of prophylactic oophorectomy and the prescription of estrogen therapy
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ESTRADIOL;
ESTROGEN;
PROGESTERONE;
ARTICLE;
BREAST CANCER;
CARDIOVASCULAR RISK;
CLINICAL PRACTICE;
COMPARATIVE STUDY;
CONTROLLED STUDY;
CREAM;
DATA ANALYSIS;
DRUG EFFICACY;
DRUG SAFETY;
EVALUATION;
FEMALE;
GEL;
GYNECOLOGY;
HEALTH;
HEALTH CARE ORGANIZATION;
HEALTH SURVEY;
HIGH RISK POPULATION;
HORMONAL THERAPY;
HORMONE SUBSTITUTION;
HUMAN;
ISCHEMIC HEART DISEASE;
MALE;
MCNEMAR TEST;
MEDICAL SPECIALIST;
OSTEOPOROSIS;
OVARIECTOMY;
PHYSICIAN ATTITUDE;
POPULATION RESEARCH;
POSTAL MAIL;
POSTMENOPAUSE;
PREMENOPAUSE;
PRESCRIPTION;
PRIORITY JOURNAL;
PRIVATE PRACTICE;
PROPHYLAXIS;
QUESTIONNAIRE;
RISK ASSESSMENT;
RISK BENEFIT ANALYSIS;
RISK FACTOR;
STATISTICAL SIGNIFICANCE;
UNIVERSITY;
VAGINA;
ADULT;
ESTROGEN REPLACEMENT THERAPY;
FEMALE;
GYNECOLOGY;
HUMANS;
OVARIAN DISEASES;
OVARIECTOMY;
PROFESSIONAL PRACTICE;
RANDOMIZED CONTROLLED TRIALS;
WOMEN'S HEALTH;
|
|
EID: 2942541460
PISSN: 00150282
EISSN: None
Source Type: Journal
DOI: 10.1016/j.fertnstert.2003.11.036 Document Type: Article |
|
Times cited : (6)
|
|
References (7)
|
